用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [IPC] 包含 'C'
  • [专利权人] 包含 'Teva Pharmaceutical Industries Ltd.'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页680 条记录, 当前第1/68页。
公开号 公开日 申请号 申请日
1. WO2012138981A3 2014/3/6
专利标题:New intermediates and processes for preparing ticagrelor 法律状态
The present invention is related to new intermediates and processes for preparing Ticagrelor disclosed in this patent application.


2. US20130296575A1 2013/11/7
专利标题:Sunitinib and salts thereof and their polymorphs 法律状态
Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.


3. KR20130042498A 2013/4/26 KR20127033454 2011/6/21
专利标题:Nilotinib salts and crystalline forms thereof 法律状态


4. US20130096304A1 2013/4/18 US13/535105 2012/6/27
专利标题:Nilotinib hcl crystalline forms 法律状态
Crystalline forms of Nilotinib HCl are described.


5. EP2571863A1 2013/3/27 EP20110728501 2011/6/21
专利标题:Nilotinib salts and crystalline forms thereof 法律状态


6. CA2591439C 2013/3/26 CA20062591439 2006/2/22
专利标题:Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof 法律状态
The present invention provides rosuvastatin and intermediates thereof having a low level of alkylether impurity and processes for the preparation thereof.


7. EP2508523A3 2013/2/27 EP20110194987 2008/10/23
专利标题:Polymorphs of dasatinib and process for preparation thereof 法律状态
The present invention relates to polymorphs of dasatinib process for preparing said polymorphs and pharmaceutical compositions thereof.


8. ES2394258T3 2013/1/30 ES20090752057T 2009/11/5
专利标题:Formas cristalinas de nilotinib hcl 法律状态
Un Nilotinib HCl cristalino caracterizado por los datos seleccionados del grupo que consiste en: un patrón dedifracción en polvo de rayos X que tiene picos a 57 98 150 158 y 173 grados dos theta ± 02 grados dos theta; unespectro de RMN de 13C de estado sólido que tiene señales a 1131 1331 1609 ± 02 ppm; un espectro de RMN de13C de estado sólido que tiene diferencias en los desplazamientos químicos entre la señal que muestra el menordesplazamiento químico y otra en el intervalo de desplazamiento ...


9. HRP20120793T1 2012/12/31 HR2012P000793T 2012/10/3
专利标题:Nilotinib hci crystalline forms 法律状态


10. US20120316175A1 2012/12/13 US13/589893 2012/8/20
专利标题:Solid state forms of sitagliptin salts 法律状态
Solid state forms of Sitagliptin salts processes for preparing the solid state forms and pharmaceutical compositions thereof are provided.



首页123456下页尾页680 条记录, 当前第1/68页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文